.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Dr Christoph Ammer-Herrmenau

Goettingen / DE

University medical center Goettingen

Speaker

Th, 15/02
16:20 – 16:25 3 Min. 2 Min.
ePoster presentation
P16
The oral microbiome is associated with preoperative imaging criteria and histological alterations in IPMN patients – a pilot study
Cystic lesions of the pancreas
Th, 15/02
16:40 – 16:45 3 Min. 2 Min.
ePoster presentation
P09
Pancreaticobiliary tumors reveal a distinct and entity-specific orointestinal microbiome
Pancreatic cancer
Fr, 16/02
09:10 – 09:20 8 Min. 2 Min.
Oral presentation
O22
Pancreatic fistula can be predicted by the oral microbiome and body mass index
Pancreatic surgery / Robotics
Fr, 16/02
12:30 – 12:50 15 Min. 5 Min.
Oral presentation
Dynamics of intestinal and intratumoral microbiome signatures in genetically engineered mice and human pancreatic ductal adenocarcinoma
Fr, 16/02
17:15 – 17:25 8 Min. 2 Min.
Oral presentation
O35
Gut microbiota predicts severity, mortality, length of hospital stay and reveals novel metabolic pathways in severe acute pancreatitis
Acute/chronic pancreatitis

Further involvements

Th, 15/02
16:20 – 16:25 3 Min. 2 Min.
ePoster presentation
P16
The oral microbiome is associated with preoperative imaging criteria and histological alterations in IPMN patients – a pilot study
Cystic lesions of the pancreas
Th, 15/02
16:40 – 16:45 3 Min. 2 Min.
ePoster presentation
P09
Pancreaticobiliary tumors reveal a distinct and entity-specific orointestinal microbiome
Pancreatic cancer
Fr, 16/02
09:10 – 09:20 8 Min. 2 Min.
Oral presentation
O22
Pancreatic fistula can be predicted by the oral microbiome and body mass index
Pancreatic surgery / Robotics
Fr, 16/02
17:15 – 17:25 8 Min. 2 Min.
Oral presentation
O35
Gut microbiota predicts severity, mortality, length of hospital stay and reveals novel metabolic pathways in severe acute pancreatitis
Acute/chronic pancreatitis
Fr, 16/02
18:05 – 18:15 8 Min. 2 Min.
Oral presentation
O40
DRACULA – drainage and flushing therapy in necrotizing pancreatitis; a retrospective, multicentric study
Acute/chronic pancreatitis
Sa, 17/02
09:50 – 10:00 8 Min. 2 Min.
Oral presentation
O52
PROTOCOL trial – PROTon pump inhibitors and stent OCclusion rate Of Lumen apposing metal stents
Acute/chronic pancreatitis
Sa, 17/02
10:35 – 10:40 3 Min. 2 Min.
ePoster presentation
P62
GSK3ß;NFATc1 Subtype-Specific targeting in pancreatic cancer
Pancreatic cancer